Skip to page content

Your kidney mass has been surgically removed and analysed by our pathology department. It has been confirmed as a renal cell carcinoma (a kidney cancer).

The stage and grade are as follows. Please see the Macmillan Cancer Support Understanding Kidney Cancer booklet for more information.

Stage T1a T1b
T2a T2b
T3a T3b T3c
T4
Grade 1 2 3 4

Based on these results you have been placed on the low risk follow up protocol.

Regular follow up is important. It enables us to monitor the remaining kidney and check for any residual or recurrent disease.

You will receive regular follow up appointments, either by telephone or face to face with your consultant or Clinical Nurse Specialist (CNS).

Your follow up will involve blood tests, CT scans and appointments at timely intervals.

We recommend 6 monthly blood tests to check your kidney function. These will need to be done through your GP’s surgery. You can get in touch with your CNS for the results.

Follow up CT scans will be scheduled for 2 years and 5 years

from your operation date (unless unavoidable delays).

If you do not receive appointments as outlined on this page by the month in which they are due, please get in touch with your CNS or your consultant’s secretary so we are aware and able to chase them up.

If you have any questions or concerns at any time between appointments please do get in contact with your CNS or your consultant’s secretary. If your call is not answered, leave a message, with your name and contact number and we will aim to return your call within 72 hours.

Clinical Nurse Specialists

Sophie Davies

0300 422 4336

sophiee.davies@nhs.net

Karen Edwards

0300 422 6672

karen.edwards6@nhs.net

Stacey Cobb

Tel: 07855 963 860

Email: stacey.cobb1@nhs.net

Consultant’s secretaries

Tel: 0300 422 6902

Monday to Friday, 8:00 am to 4:00 pm

Printable version of this page

Low Risk Protocol for Kidney Cancer GHPI1740_06_25 Department: Urology Review due: June 2028 PDF, 326.4 KB, 3 pages
Reference number GHPI1740_06_25
Department Urology
Review due June 2028